Clinical trial of potential coronavirus treatment hydroxychloroquine begins, NIH says
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.
A human clinical trial for an antimalarial drug touted as a possible treatment option for patients with COVID-19 infections began this week, according to the National Institute of Health (NIH).
The NIH in a news release on Thursday said a clinical trial for the drug hydroxychloroquine began with the first participants enrolled at Vanderbilt University Medical Center in Nashville, Tenn. The trial involves some 500 adults “who are currently hospitalized with COVID-19 or in an emergency department with anticipated hospitalization,” officials said.
The trial is placebo-controlled and randomized, meaning some of the patients will be treated with hydroxychloroquine while others will not. However, “all participants in the study will continue to …continued .
[Source: Fox News]